Financing the acceleration of the progress needed to reach the 2030 targets was highlighted throughout the global consultation on which the NTD road map 2021-2030 was based. For some time, a lack of resources has been seen as a significant barrier to control, elimination and eradication. This challenge has only been intensified by the COVID-19 pandemic; indeed, the pandemic has altered the course of many public health objectives for the near and long terms alike. In response to the need to raise the funding and resources highlighted by the global neglected tropical disease community, the World Health Organization prepared this rationale for global investment as an advocacy document to support and augment the implementation of the road map. This rationale was developed in an already complex funding landscape and in the context of a wide-ranging and diverse set of diseases. It was also prepared against a background of unprecedented cuts to aid budgets and shifting international priorities. This document sets out, therefore, to explain the socioeconomic value of investing in the fight against neglected tropical diseases and highlights priorities for global investment attention. Our work was guided by the need not only for additional funding and funders but also for the need to understand the current funding climate, in which value for money and the efficient use of resources to fill the most critical of gaps are more relevant than ever.

This companion document to Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021-2030 (“the road map”) aims to support a range of stakeholders – including countries in which neglected tropical diseases (NTDs) are endemic, international organizations and non-State actors – to achieve the road map targets through a transdisciplinary, cross-cutting One Health approach. The document has six sections.

In September 2015, the United Nations General Assembly adopted the 17 Sustainable Development Goals (SDGs). This historic document constituted a transformative 'plan for action for people, planet and prosperity' with regards to the sustainable development efforts of all countries. The Sustainable Development Goals serves as an expert compendium, the most authoritative ready-reference tool for anyone interested in the SDGs. Each chapter comprises a detailed target-by-target analysis of one of the SDGs, including a methodical analysis of the preparatory proceedings that shaped each goal in its present form, an exhaustive examination of their content, and a critical assessment from an international law perspective. This commentary provides readers with the most up-to-date information on normative and legal questions arising from the incorporation of the SDGs into the international economic, social, and environmental legal frameworks, and on their implementation status. Scholars, practitioners, and those interested in the fields of law, politics, development, economics, environmental studies, and global governance will find this book a must-read.

This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators presented in the M&E framework. These indicators will also support reporting on strategies described in other road map companion documents to guide action against neglectedtropical diseases include the sustainability framework, the global strategy on water, sanitation and hygiene, the One Health approach and the strategic framework for integrated control and elimination of skin-related neglected tropical diseases. The purpose of this compendium is to guide monitoring and evaluation of programmes and thereby to improve their quality and effectiveness in alignment with the road map goals. It provides a standardized listing of the most widely used indicators relevant to countries, with uniformity in defining indicators to allow comparisons over time and among different programmes. Detailed metadata are provided for each of these indicators to facilitate validity, internal consistency, standardized measurement, estimation methods and comparability of data across countries.

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.